Please remember that the value of an investment and the income from it can go down as well as up and you may get back less than you invested.
We don't provide advice so if you are in any doubt about making your own investment decisions we recommend you seek advice from a suitably qualified financial adviser.
Welcome to the Halifax marketwatch. Use our range of tools and up to date market research to find out what is happening and where. Please note that unless otherwise stated the information contained within the Halifax marketwatch Research Centre is provided by Digital Look Ltd.
Thursday 17 Aug 2017
(ShareCast News) - Hikma Pharmaceuticals reported a 1% rise in first-half sales and flat profits, but trimmed its guidance for the full year as the generic drugs arm faces tougher market conditions and continues discussions with US regulators over a key generic asthma drug.
|Name||Value Today||Change||Change %|
|FTSE Small Cap||5717||6.16||0.11|
|FTSE AIM All-Share||1005||2.10||0.21|
|FTSE AIM 50||5807||14.14||0.24|
|FTSE AIM 100||5135||14.00||0.27|
|Dow Jones I.A.||22025||25.88||0.12|
Monitor your chosen stocks with a watchlist.
Our education centre is full of
useful guides, virtual online tours and lots of FAQs to get you started.